LCI Learning

Share on Facebook

Share on Twitter

Share on LinkedIn

Share on Email

Share More

Riya Sharma (Professional )     12 September 2012

Pharma legal & compliance summit 2012

 


 

 

The recent proposal by government to codify ethics for pharma companies with uniform code of pharmaceutical marketing practices and recent changes in MCI guidelines and DGCI guidelines on gifting to doctors and medical profession means that it is no longer business as usual. With increased competitive pressure and closer scrutiny of regulators and other stakeholders, there is now an urgent need for pharmaceutical companies to proactively manage their internal process on governance, ethics and compliance to protect against potential financial penalties, possible product withdrawals and damaged reputations. And with significant investment in R&D by Pharma companies, high level of collaboration and cooperation between Indian and multinational pharma companies in contract research and manufacturing, managing and negotiating contracts and licensing agreements and having an effective patent strategy becomes more important than ever to avoid disputes which have an adverse financial and reputational impact on both parties. In view of the above Lex Witness presents India’s first comprehensive discussions dealing with important issues affecting the industry on governance, ethics, compliance, contracts management, licensing agreements and developing a proactive legal strategy for patent litigations.

 

 

The conference will feature more than 20+ expert speakers who will share their thoughts on the following:

 

 

1. Fraud and Corruption Management

2. Legal and regulatory compliance of ethics for pharmaceutical and bio-pharma companies in India

3. Legal risk management strategies for new product launches

4. Current regulatory developments & implications of changes to regulatory framework

5. Trends in patent opposition and litigation

6. Recent developments in pre-grant and post-grant opposition

7. Settlement strategies

8. Key elements of a compliance programme

9. Recent changes in clinical trials documentation requirements in India

10. Current Legal issues in Domestic & Cross Border site contracts

11. Contracts, Claims & Counter Claims & Licensing agreements 

 

 

Focus groups: 

 

 

Law firms

Pharma firms

Bio tech firms

Bio pharma firms

Copyright societies

 

 

Date: 05 October 2012

Venue: Hotel Holiday Inn, Mumbai 

 

Link: https://lawyersclubindia.com/witness/pharma.htm  

 

 

Registration Fees: 

 

 

FOR CORPORATES

 

 

1 Delegate - INR 8,000      ( 7600 for LAWyersclubindia and CAclubindia members ) 

2 Delegates - INR 15,000

3 Delegates - INR 18,000

 

 

FOR LAW FIRMS

 

 

1 Delegate - INR 10,000

2 Delegates - INR 17,000

3 Delegates - INR 22,000

 

 

Taxes Extra as Applicable

 

 

Date: 5th October 2012, 

Venue: Hotel Holiday Inn, Mumbai  

 

5% special discount for LAWyersclubindia.com members.

 

 

Contact: 


Praveen Sharma                                              

Ph- 9213750140  


 

 



Learning

 0 Replies


Leave a reply

Your are not logged in . Please login to post replies

Click here to Login / Register